期刊文献+

检测金属基质蛋白酶及其抑制物对判断膀胱癌浸润和转移的意义 被引量:4

Expression of MMP-2, MMP-9, TIMP-2 in bladder carcinoma as a prognostic marker
原文传递
导出
摘要 目的 探讨金属基质蛋白酶 (MMP)及其抑制物检测在判断膀胱癌恶性度及预后中的作用。 方法 采用Westernblot和RT PCR方法 ,检测人膀胱肿瘤组织中MMP 2、MMP 9、TIMP 2蛋白表达和MMP 2、TIMP 2基因表达 ,应用计算机图像分析测定表达电泳条带的吸光度A值。 结果 膀胱肿瘤组织MMP 2、MMP 9、TIMP 2蛋白与基因表达与正常膀胱组织比较 ,差别有显著性意义 (P <0 .0 1) ;膀胱肿瘤组织TIMP 2蛋白与基因的吸光度A平均值与正常膀胱组织比较 ,差别无显著性意义 (P >0 .0 5 )。表浅膀胱癌组织的MMP 2 /TIMP 2蛋白、基因吸光度A平均值比率与正常膀胱组织比较 ,差别有显著性意义 (P <0 .0 5 ) ;浸润性膀胱癌的MMP 2 /TIMP 2蛋白、基因吸光度A平均值比率与正常膀胱组织相比 ,差别有显著性意义 (P <0 .0 1)。G2 、G3 与G1的MMP 2 /TIMP 2平均吸光度A值比率差别有显著性意义 (P <0 .0 1)。 结论 MMP 2、MMP 9表达和MMP 2 /TIMP 2比率对判断膀胱肿瘤浸润及转移有一定意义。检测MMP 2 /TIMP 2比率失衡较单纯检测MMP 2、TIMP Objective To detect both the protein and gene expression of matrix metalloproteinase (MMP 2,MMP 9) and its tissue inhibitor (TIMP 2) in tissues of bladder transitional cell carcinoma (BTCC), and to study the correlation with the grading and staging of the neoplasm and with the prognosis. Methods 41 human BTCC ,15 normal bladder tissue were studied by Western Blot and RT PCR analysis followed by computer assisted image analysis in order to detect the A values of their expression. Results In BTCC, the A value of MMP 2, MMP 9 were increased significantly as compared to normal bladder epithelium. There was no statistical significant difference of A value of TIMP 2 between normal bladder tissue and bladder cancer tissue. The ratio of MMP 2/TIMP 2 in bladder cancer showed statistical significantly difference as compared with normal bladder tissue. Conclusions This study demonstrated there was a high expression of MMP 2 and MMP 9 in BTCC,by which collagen Ⅳ inside basement membrane of bladder was damaged.However, the ratio of MMP 2/TIMP 2 has more prognostic value than the expression of MMP 2 and MMP 9 alone.
出处 《中华泌尿外科杂志》 CAS CSCD 北大核心 2002年第4期231-233,共3页 Chinese Journal of Urology
关键词 金属基质蛋白酶 抑制物 膀胱癌 浸润 转移 肿瘤浸润 肿瘤转移 Bladder neoplasms Carcinoma,transitional cell Metalloprotein
  • 相关文献

参考文献12

  • 1Liu BC,Neuwirth H,Zhu LW,et al.Detection of onco-fetal bladder antigen in urine of patients with transitional cell carcinoma.J Urol,1987,137:1258-1261.
  • 2Burchill SA,Bradbury MF,Pittman K,et al.Detection of epithelial cancer cells in peripheral blood by reverse transcriptase-polymerase chain reaction.Br J Cancer,1995,71:278-281.
  • 3Davies R,Waxman J,Wasan H,et al.Levels of matrix metalloproteinases in bladder cancer correlate with tumor grade and invasion.Cancer Res,1993,53:5365-5369.
  • 4Furukawa A,Tsuji M,Nishitani M,et al.Role of the matrix metalloproteinases and tissue inhibitors of metalloproteinases families in noninvasive and invasive tumors transplanted in mice with severe combined immunodeficience.Urology,1998,51:849-853.
  • 5Jung K,Lein M,Ulbrich N,et al.Quantification of matrix metalloproteinases and tissue inhibitors of metalloproteinases in prostatic tissue:analytical aspects.The Prostate,1998,34:130-135.
  • 6Moses MA,Wiederschain D,Loughlin KR,et al.Increased incidence of matrix metalloproteinases in urine of cancer patients.Cancer Res,1998,58:1395-1399.
  • 7Kanayama H,Yokota K,Kurokawa Y,et al.Prognostic values of matrix metalloproteinases-2 and tissue inhibitor of metalloproteinases-2 expression in bladder cancer.Cancer,1998,82:1359-1366.
  • 8Lokeshwar BL.MMP inhibition in prostate cancer.Ann NY Acad Sci,1999,30:271-289.
  • 9Rabbani SA.Metalloproteinase and urokinase in angiogenesis and tumor progression.In Vivo,1998,12:135-142.
  • 10Lokeshwar BL,Selzer MG,Block NL,et al.Secretion of matrix metalloproteinases and their inhibitors by human prostate in explant cultures:reduced tissue inhibitor of metalloproteinases secretion by malignant tissues.Cancer Res,1993,53:4493-4498.

同被引文献30

  • 1张立达,杨玉秀,夏永欣.MMP-7和FasL在大肠癌的表达及其相互作用[J].河南医学研究,2005,14(2):122-125. 被引量:2
  • 2胡元晶,曲芃芃.VEGF及其受体在上皮性卵巢癌中的表达及与血管生成的关系[J].中国肿瘤临床,2006,33(23):1346-1349. 被引量:10
  • 3黄杰雄 张永海 林莹 等.MMP—2和MMP—9与膀胱癌侵袭、复发的关系[J].肿瘤研究与临床,2001,13(1):22-22.
  • 4Furukawa A, Tsuji M, Nishitani M, et al. Role of the matrix metallo -proteinase and tissue transplanted in mice with severe combined immunodeficiency. Urology, 1997,25:580 - 584.
  • 5Goldverg GJ. Stmngin A, Collier IE, et al. Interaction of 92kDa type Ⅳ collagenase with tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase and activation of proenzyme with stromelysin. J Biol Chem, 1992,267:4583-4591.
  • 6Watanable M, Takhashi Y, Ohta T, et al. Inhibition of metastasis in human gastrie cancer cells transfected with tissue inhibitor of metalloproteinase 1 gene in nude mice. Cancer 1996,77:1676 -1680.
  • 7Chesler L, Golde DW, Bersch N, et al. Metalloproteinase inhibition and erythroid potentiation aew independent activities of tisse inhibitor of metalloproteinase - 1. Blood, 1995,86:4506 - 4515.
  • 8Murray GI, Duncan ME, Arbuckle E, et al. Matrix metalloproteinases and their inhibitors in gastric cancer. Gut, 1998,43:791-797.
  • 9Volper OL, Hopwood D, Newman EL, et al. Combined analysis of p53 and TSP - 1 in nonsmall cell carcinoma. Oncogene. 1997,14:1495.
  • 10Davies B, Wax man J, Waxan H, et al. Levels of matrix metalloproteinases in bladder cancer correlate with tumor grade and invasion. Cancer Res, 1993,84:841-850.

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部